Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma

被引:7
作者
Chen, Chujie [1 ]
Sheng, Yiyu [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Urol, 628 Zhenyuan Rd, Shenzhen 518017, Peoples R China
关键词
MITD1; KIRC; TCGA; bioinformatics; CD8+T cells; GENE; IDENTIFICATION; MANAGEMENT; PROFILES;
D O I
10.1177/15330338211036233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kidney renal clear cell carcinoma (KIRC) is one of the most malignant diseases with poor survival rate over the world. The tumor microenvironment (TME) is highly related to the oncogenesis, development, and prognosis of KIRC. Thus, making the identification of KIRC biomarkers and immune infiltrates critically important. Microtubule Interacting and Trafficking Domain containing 1(MITD1) was reported to participate in cytokinesis of cell division. In the present study, multiple bioinformatics tools and databases were applied to investigate the expression level and clinical value of MITD1 in KIRC. We found that the expression of MITD1 was significantly increased in KIRC tissues. Further, the KIRC patients with high MITD1 levels showed a worse overall survival (OS) rate and disease free survival (DFS) rate. Otherwise, we found a significant correlation MITD1 expression and the abundance of CD8+ T cells. Functional enrichment analyses revealed that immune response and cytokine-cytokine receptor are very critical signaling pathways which associated with MITD1 in KIRC. In conclusion, our findings indicated that MITD1 may be a potential biomarker and associated with immune infiltration in KIRC.
引用
收藏
页数:9
相关论文
共 39 条
  • [1] Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
    Atkins, M. B.
    Clark, J. I.
    Quinn, D. I.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (07) : 1484 - 1494
  • [2] Treatment of renal cell carcinoma: Current status and future directions
    Barata, Pedro C.
    Rini, Brian I.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) : 507 - 524
  • [3] Papillary renal cell carcinoma: A review of the current therapeutic landscape
    Courthod, Giulia
    Tucci, Marcello
    Di Maio, Massimo
    Scagliotti, Giorgio V.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (01) : 100 - 112
  • [4] Delahunt B, 1997, MODERN PATHOL, V10, P537
  • [5] CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
    Farhood, Bagher
    Najafi, Masoud
    Mortezaee, Keywan
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 8509 - 8521
  • [6] A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
    Fernandez-Pello, Sergio
    Hofmann, Fabian
    Tahbaz, Rana
    Marconi, Lorenzo
    Lam, Thomas B.
    Albiges, Laurence
    Bensalah, Karim
    Canfield, Steven E.
    Dabestani, Saeed
    Giles, Rachel H.
    Hora, Milan
    Kuczyk, Markus A.
    Merseburger, Axel S.
    Powles, Thomas
    Staehler, Michael
    Volpe, Alessandro
    Ljungberg, Borje
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 426 - 436
  • [7] Recent progress in the management of advanced renal cell carcinoma
    Garcia, Jorge A.
    Rini, Brian I.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (02) : 112 - 125
  • [8] Immunity, Inflammation, and Cancer
    Grivennikov, Sergei I.
    Greten, Florian R.
    Karin, Michael
    [J]. CELL, 2010, 140 (06) : 883 - 899
  • [9] ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes
    Hornung, Tassilo
    O'Neill, Heather A.
    Logie, Stephen C.
    Fowler, Kimberly M.
    Duncan, Janet E.
    Rosenow, Matthew
    Bondre, Aniket S.
    Tinder, Teresa
    Maher, Varun
    Zarkovic, Jelena
    Zhong, Zenyu
    Richards, Melissa N.
    Wei, Xixi
    Miglarese, Mark R.
    Mayer, Gunter
    Famulok, Michael
    Spetzler, David
    [J]. NUCLEIC ACIDS RESEARCH, 2020, 48 (08) : 4013 - 4027
  • [10] Renal cell carcinoma
    Hsieh, James J.
    Purdue, Mark P.
    Signoretti, Sabina
    Swanton, Charles
    Albiges, Laurence
    Schmidinger, Manuela
    Heng, Daniel Y.
    Larkin, James
    Ficarra, Vincenzo
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2017, 3